Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$3.26 - $4.66 $41,369 - $59,135
-12,690 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$4.08 - $5.66 $1,464 - $2,031
-359 Reduced 2.75%
12,690 $57,000
Q2 2021

Aug 13, 2021

BUY
$5.01 - $7.48 $65,375 - $97,606
13,049 New
13,049 $71,000
Q3 2020

Nov 13, 2020

SELL
$8.69 - $14.47 $106,713 - $177,691
-12,280 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$5.21 - $11.03 $63,978 - $135,448
12,280 New
12,280 $131,000
Q3 2018

Nov 14, 2018

SELL
$9.74 - $12.92 $168,531 - $223,554
-17,303 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$10.16 - $13.65 $175,798 - $236,185
17,303 New
17,303 $177,000

About Syros Pharmaceuticals, Inc.


  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.